Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 2,812 followers.

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer https://t.co/aRRBtVNBpR

Reply Repost Favourite

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer #JIRSecondaryAntibodies https://t.co/h78sq7OG03

Reply Repost Favourite

RT @JournalofExper1: Online! 🔦 𝐌𝐨𝐝𝐞𝐥𝐥𝐢𝐧𝐠 𝐡𝐲𝐩𝐞𝐫𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐭𝐨 #𝐭𝐫𝐚𝐬𝐭𝐮𝐳𝐮𝐦𝐚𝐛 𝐝𝐞𝐟𝐢𝐧𝐞𝐬 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐨𝐟 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐞 𝐢𝐧 #𝐇𝐄𝐑𝟐 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞𝐚𝐬𝐭𝐜𝐚𝐧𝐜𝐞𝐫…

Reply Repost Favourite

Online! 🔦 𝐌𝐨𝐝𝐞𝐥𝐥𝐢𝐧𝐠 𝐡𝐲𝐩𝐞𝐫𝐬𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 𝐭𝐨 #𝐭𝐫𝐚𝐬𝐭𝐮𝐳𝐮𝐦𝐚𝐛 𝐝𝐞𝐟𝐢𝐧𝐞𝐬 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐨𝐟 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐞 𝐢𝐧 #𝐇𝐄𝐑𝟐 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 #𝐛𝐫𝐞𝐚𝐬𝐭𝐜𝐚𝐧𝐜𝐞𝐫 Have a look here 👇 https://t.co/8ocpCsldAq @IREISGufficiale https://t.co/CTpkPqcs9Z

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.